Recent advances in understanding and managing resistant/refractory hypertension [version 1; peer review: 2 approved]
The management of resistant hypertension presents several challenges in everyday clinical practice. During the past few years, several studies have been performed to identify efficient and safe pharmacological and non-pharmacological options for the management of such patients. The Spironolactone ve...
Main Authors: | Michael Doumas, Konstantinos P Imprialos, Manolis S Kallistratos, Athanasios J Manolis |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-03-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/9-169/v1 |
Similar Items
-
Recent advances in understanding frontotemporal degeneration [version 1; peer review: 2 approved]
by: Barbara Borroni, et al.
Published: (2019-12-01) -
Blood pressure reduction and control with fixed-dose combination perindopril/amlodipine: A Pan-Hellenic prospective observational study
by: Athanasios Manolis, et al.
Published: (2015-12-01) -
Recent advances in understanding mesenchymal stromal cells [version 1; peer review: 3 approved]
by: Erika Rendra, et al.
Published: (2020-02-01) -
Recent advances in understanding chemotherapy-induced peripheral neuropathy [version 1; peer review: 2 approved]
by: Richard Gordon-Williams, et al.
Published: (2020-03-01) -
Recent advances in understanding Candida albicans hyphal growth [version 1; peer review: 4 approved]
by: Robert A. Arkowitz, et al.
Published: (2019-05-01)